🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare progression-free survival (PFS) from rand...
Status
Completed
Location
University of Alabama
Start Date
2015-08
Trial ID
NCT02440464
Treatments Being Tested
This research study is evaluating a drug called ixazomib (also known as MLN...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2015-04
Trial ID
NCT02400437
Treatments Being Tested
The purpose of this study is to evaluate the safety of NINLARO in participa...
Status
Completed
Location
Takeda Selected Site
Start Date
2017-05-24
Trial ID
NCT03169361
Treatments Being Tested
This is a phase 2, multicenter, open-label study in patients with Newly Dia...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-05
Trial ID
NCT02046070
Treatments Being Tested
This phase II trial studies how well ixazomib works in treating patients wi...
Status
Recruiting
Location
UC San Diego
Start Date
2023-11-07
Trial ID
NCT04305691
Treatments Being Tested
This research study is evaluating drugs called Millennium 9708 (referred to...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-01
Trial ID
NCT02582359
Treatments Being Tested
This phase Ib trial studies side effects and best dose of pevonedistat when...
Status
Completed
Location
Smilow Cancer Center/Yale-New Haven Hospital
Start Date
2020-02-10
Trial ID
NCT03770260
Treatments Being Tested
This phase II trial studies how well pembrolizumab works when given togethe...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2018-06-19
Trial ID
NCT03506360
Treatments Being Tested
The purpose of the study is to determine the safety of MLN9708 as maintenan...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2014-09
Trial ID
NCT02168101
Treatments Being Tested
This study is a Multicenter, Open-label, Phase II study of ixazomib, plus P...
Status
Terminated
Location
CHU Angers
Start Date
2019-11-03
Trial ID
NCT03683277
Treatments Being Tested